GE HealthCare Technologies Inc.
NASDAQ:GEHCMedical - Healthcare Information Services
+$0.45 today
- Market cap
- $37.83B
- Beta
- 0.86
- P/E (TTM)
- 18.7
- EPS (TTM)
- $3.30
- Dividend yield
- 0.23%
Volume 3.65M
Average 4.84M
GEHC Debt Repayment
Cash used to repay borrowings during the period.
GE HealthCare Technologies Inc.NASDAQ: GEHC
Debt Repayment · Q2 FY2026 · quarter ended Jun 2026
Debt repayment outflow shrinks to $0
Q2 FY2026 debt repayment was $0, compared with $1.49B a year earlier. Trailing-twelve-month debt repayment was -$118M. Over 3 fiscal years it compounded at -51.0% a year.
Context
- Debt repayment amounted to 4.7% of revenue in FY2025, up 2.5 pp from a year earlier.
- Debt repayment increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly debt repayment holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$29.5M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Debt Repayment history
USD · from the cash flow
- Latest · FY2025
- 967M USD
- Year-over-year change
- +328.6%
| Period | Period end | Debt Repayment | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 967M | +328.6% |
| FY2024 | 2024-12-31 | (423M) | -137.1% |
| FY2023 | 2023-12-31 | 1.14B | -86.1% |
| FY2022 | 2022-12-31 | 8.2B | +68466.7% |
| FY2021 | 2021-12-31 | (12M) | — |
Debt Repayment vs competitors
How GEHC compares with its peers on the latest reported figures
- Peers report in different currencies, so debt repayment is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -112.2% is the 4th highest of 6, against a peer median of +115.7%.
- Debt repayment amounts to 0.6% of revenue for GEHC, versus a peer median of 6.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $16.44B USD | +1114.1% | +32.2% | 35.3% | |
| LTM Jun 2026 | $2.15B USD | -155.5% | +49.6% | 8.3% | |
| LTM Jun 2026 | €1.13B EUR | -243.1% | -26.9% | 6.4% | |
| LTM Jun 2026 | $979M USD | +579.9% | +43.8% | 4.7% | |
| LTM Jul 2026 | $151M USD | +115.7% | +25.2% | 0.4% | |
| LTM Jun 2026 | $118M USD | -112.2% | -51.0% | 0.6% | |
| Peer median (excluding GEHC) | — | +115.7% | +32.2% | 6.4% | |
Competitors are the stored peer set for GEHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.28B | 1.95B | 1.62B | 2.05B | 2.15B |
| Depreciation & Amortization | 625M | 633M | 610M | 580M | 578M |
| Deferred Income Tax | 600M | 563M | 743M | 531M | 0 |
| Stock-Based Compensation | 76M | 67M | 114M | 125M | 130M |
| Change in Working Capital | (1.37B) | (293M) | 22M | (59M) | (357M) |
| Accounts Receivables | (1.16B) | (440M) | (171M) | (150M) | (216M) |
| Inventory | (435M) | (402M) | 111M | (81M) | (142M) |
| Accounts Payables | 263M | 481M | (13M) | 126M | 90M |
| Other Working Capital | (42M) | 68M | 95M | 46M | (89M) |
| Other Non-Cash Items | (599M) | (806M) | (1.01B) | (1.28B) | (517M) |
| Operating Cash Flow | 1.61B | 2.11B | 2.1B | 1.95B | 1.99B |
| Capital Expenditures | (248M) | (310M) | (387M) | (401M) | (482M) |
| Acquisitions (Net) | (1.48B) | 0 | (147M) | (313M) | 0 |
| Purchases of Investments | 0 | (59M) | (48M) | (40M) | (118M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (32M) | (29M) | 24M | (160M) | (447M) |
| Investing Cash Flow | (1.76B) | (398M) | (558M) | (914M) | (1.05B) |
| Debt Repayment | (12M) | 8.2B | 1.14B | (423M) | 967M |
| Common Stock Issued | 0 | 0 | 0 | 33M | 37M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (200M) |
| Dividends Paid | 0 | 0 | (41M) | (55M) | (64M) |
| Other Financing Activities | (251M) | (9.03B) | (1.58B) | (128M) | (123M) |
| Financing Cash Flow | (263M) | (822M) | (478M) | (573M) | 617M |
| Effect of Forex Changes | (34M) | (3M) | (10M) | (77M) | 64M |
| Net Change in Cash | (451M) | 890M | 1.06B | 387M | 1.62B |
| Free Cash Flow | 1.36B | 1.8B | 1.71B | 1.55B | 1.51B |
GE HealthCare Technologies Inc.
NASDAQ:GEHC
Intrinsic Alpha fair value
Locked
Current Price
$83.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.